BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paudel S, Zacharioudakis IM, Zervou FN, Ziakas PD, Mylonakis E. Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies. PLoS One 2015;10:e0124483. [PMID: 25886133 DOI: 10.1371/journal.pone.0124483] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Gomez-Simmonds A, Annavajhala MK, Nunez MP, Macesic N, Park H, Uhlemann AC. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients. mSphere 2022;:e0036122. [PMID: 36135360 DOI: 10.1128/msphere.00361-22] [Reference Citation Analysis]
2 Dudzicz-gojowy S, Więcek A, Adamczak M. Clostridioides difficile Infection in Patients after Organ Transplantation—A Narrative Overview. JCM 2022;11:4365. [DOI: 10.3390/jcm11154365] [Reference Citation Analysis]
3 Boeriu A, Roman A, Fofiu C, Dobru D. The Current Knowledge on Clostridioides difficile Infection in Patients with Inflammatory Bowel Diseases. Pathogens 2022;11:819. [DOI: 10.3390/pathogens11070819] [Reference Citation Analysis]
4 Faucher Q, Jardou M, Brossier C, Picard N, Marquet P, Lawson R. Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus? Front Endocrinol 2022;13:898878. [DOI: 10.3389/fendo.2022.898878] [Reference Citation Analysis]
5 Blumberg EA, Collins G, Young JH, Nguyen MH, Michonneau D, Temesgen Z, Origȕen J, Barcan L, Obeid KM, Belloso WH, Gras J, Corbelli GM, Neaton JD, Lundgren J, Snydman DR, Molina JM; INSIGHT Clostridioides difficile Study Group. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study. Transpl Infect Dis 2021;:e13770. [PMID: 34821423 DOI: 10.1111/tid.13770] [Reference Citation Analysis]
6 Bernard R, Hourigan SK, Nicholson MR. Fecal Microbiota Transplantation and Microbial Therapeutics for the Treatment of Clostridioides difficile Infection in Pediatric Patients. J Pediatric Infect Dis Soc 2021;10:S58-63. [PMID: 34791396 DOI: 10.1093/jpids/piab056] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Kortt NC, Santhakumar C, Davis RJ, Strasser SI, McCaughan GW, Liu K, Majumdar A. Prevalence and outcomes of Clostridioides difficile infection in liver transplant recipients. Transpl Infect Dis 2021;:e13758. [PMID: 34762768 DOI: 10.1111/tid.13758] [Reference Citation Analysis]
8 Ortiz-Balbuena J, Royuela A, Calderón-Parra J, Martínez-Ruiz R, Asensio-Vegas Á, Múñez E, Valencia-Alijo Á, Gutiérrez-Rojas Á, Ussetti P, Cuervas-Mons V, Segovia-Cubero J, Portolés-Pérez J, Ramos-Martínez A. Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients. Transplant Proc 2021:S0041-1345(21)00713-2. [PMID: 34772488 DOI: 10.1016/j.transproceed.2021.09.047] [Reference Citation Analysis]
9 Amjad W, Qureshi W, Malik A, Singh R, Jafri SM. The outcomes of Clostridioides difficile infection in inpatient liver transplant population. Transpl Infect Dis 2021;:e13750. [PMID: 34695277 DOI: 10.1111/tid.13750] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ancona G, Alagna L, Lombardi A, Palomba E, Castelli V, Renisi G, Dondossola D, Iavarone M, Muscatello A, Gori A, Bandera A. The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections. Infect Immun 2021;89:e0037621. [PMID: 34460287 DOI: 10.1128/IAI.00376-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Meyer F, Weil-Verhoeven D, Prati C, Wendling D, Verhoeven F. Safety of biologic treatments in solid organ transplant recipients: A systematic review. Semin Arthritis Rheum 2021;51:1263-73. [PMID: 34507811 DOI: 10.1016/j.semarthrit.2021.08.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Obeid KM, Sapkota S, Cao Q, Richmond S, Watson AP, Karadag FK, Young JH, Pruett T, Weisdorf DJ, Ustun C. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients. Transpl Infect Dis 2021;:e13720. [PMID: 34455662 DOI: 10.1111/tid.13720] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Sahra S, Abureesh M, Amarnath S, Alkhayyat M, Badran R, Jahangir A, Gumaste V. Clostridioides difficile infection in liver cirrhosis patients: A population-based study in United States. World J Hepatol 2021; 13(8): 926-938 [PMID: 34552699 DOI: 10.4254/wjh.v13.i8.926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yepez Guevara EA, Aitken SL, Olvera AV, Carlin L, Fernandes KE, Bhatti MM, Garey KW, Adachi J, Okhuysen PC. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes. Clin Infect Dis 2021;72:e460-5. [PMID: 32803229 DOI: 10.1093/cid/ciaa1184] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 2021;116:1124-47. [PMID: 34003176 DOI: 10.14309/ajg.0000000000001278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 36] [Article Influence: 1.0] [Reference Citation Analysis]
16 Johnson TM, Howard AH, Miller MA, Allen LL, Huang M, Molina KC, Bajrovic V. Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients. Open Forum Infect Dis 2021;8:ofab294. [PMID: 34262988 DOI: 10.1093/ofid/ofab294] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Gotshal D, Azrad M, Hamo Z, Nitzan O, Peretz A. IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of C. difficile Infection. Pathogens 2021;10:631. [PMID: 34065379 DOI: 10.3390/pathogens10050631] [Reference Citation Analysis]
18 Non LR, Ince D. Infectious Gastroenteritis in Transplant Patients. Gastroenterol Clin North Am 2021;50:415-30. [PMID: 34024449 DOI: 10.1016/j.gtc.2021.02.013] [Reference Citation Analysis]
19 Agrawal A, Ison MG, Danziger-Isakov L. Long-Term Infectious Complications of Kidney Transplantation. Clin J Am Soc Nephrol 2021:CJN. [PMID: 33879502 DOI: 10.2215/CJN.15971020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 McCreery RJ, Florescu DF, Kalil AC. Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus. J Infect Dis 2020;222:S156-65. [PMID: 32691837 DOI: 10.1093/infdis/jiaa320] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
21 Khurana S, Kahl A, Yu K, DuPont AW. Recent advances in the treatment of Clostridioides difficile infection: the ever-changing guidelines. Fac Rev 2020;9:13. [PMID: 33659945 DOI: 10.12703/b/9-13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 Lam AY, Gutin LS, Nguyen Y, Velayos FS. Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients. Dig Dis Sci 2020;65:3111-5. [PMID: 32749638 DOI: 10.1007/s10620-020-06521-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Dudzicz S, Adamczak M, Więcek A. Clostridium difficile infection in patients after solid organ transplantations. Postepy Hig Med Dosw 2020;74:198-204. [DOI: 10.5604/01.3001.0014.2022] [Reference Citation Analysis]
24 Mayer EF, Maron G, Dallas RH, Ferrolino J, Tang L, Sun Y, Danziger-Isakov L, Paulsen GC, Fisher BT, Vora SB, Englund J, Steinbach WJ, Michaels M, Green M, Yeganeh N, Gibson JE, Dominguez SR, Nicholson MR, Dulek DE, Ardura MI, Rajan S, Gonzalez BE, Beneri C, Herold BC. A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients. Am J Transplant 2020;20:2133-42. [PMID: 32064754 DOI: 10.1111/ajt.15826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Okamoto K, Santos CAQ. Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients. Ann Transl Med 2020;8:413. [PMID: 32355857 DOI: 10.21037/atm.2020.01.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
26 Cheung DA, Beduschi T, Tekin A, Selvaggi G, Ruiz P, Vianna RM, Garcia J. Clostridium difficile infection mimics intestinal acute cellular rejection in pediatric multivisceral transplant—A case series. Pediatr Transplant 2020;24. [DOI: 10.1111/petr.13621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
27 McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:e1-e48. [PMID: 29462280 DOI: 10.1093/cid/cix1085] [Cited by in Crossref: 718] [Cited by in F6Publishing: 809] [Article Influence: 239.3] [Reference Citation Analysis]
28 Westblade LF, Satlin MJ, Albakry S, Botticelli B, Robertson A, Alston T, Magruder M, Zhang LT, Edusei E, Chan K, Lubetzky M, Dadhania DM, Pamer EG, Suthanthiran M, Lee JR. Gastrointestinal pathogen colonization and the microbiome in asymptomatic kidney transplant recipients. Transpl Infect Dis. 2019;21:e13167. [PMID: 31502737 DOI: 10.1111/tid.13167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
29 Schluger A, Rosenblatt R, Knotts R, Verna EC, Pereira MR. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients. Transpl Infect Dis 2019;21:e13184. [PMID: 31571380 DOI: 10.1111/tid.13184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
30 Carney KC, Bronzell-wynder T, Gronek K. Lung Transplant for the Critical Care Nurse. Critical Care Nursing Clinics of North America 2019;31:285-302. [DOI: 10.1016/j.cnc.2019.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Parmar NV, Glauser J. Systematic Review of Current Treatment and Prevention Strategies for Clostridium difficile. Curr Emerg Hosp Med Rep 2019;7:66-73. [DOI: 10.1007/s40138-019-00186-1] [Reference Citation Analysis]
32 . Hygienemaßnahmen bei Clostridioides difficile-Infektion (CDI): Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsbl 2019;62:906-23. [DOI: 10.1007/s00103-019-02959-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
33 Mullane KM, Dubberke ER; AST ID Community of Practice. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice. Clin Transplant 2019;33:e13564. [PMID: 31002420 DOI: 10.1111/ctr.13564] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
34 Duclaux-Loras R, Berthiller J, Ferroni A, Chardot C, Goulet O, Lacaille F, Norsa L. Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation. Transplantation 2020;104:197-200. [PMID: 31205257 DOI: 10.1097/TP.0000000000002795] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
35 Jorgenson MR, Descourouez JL, Yang DY, Leverson GE, Saddler CM, Smith JA, Safdar N, Mandlebrot DA, Redfield RR. Epidemiology, Risk Factors, and Outcomes After Early Posttransplant Clostridiodes difficile Infection in Renal Transplant Recipients. Ann Pharmacother 2019;53:1020-5. [PMID: 31007034 DOI: 10.1177/1060028019845003] [Reference Citation Analysis]
36 Vaishnavi C, Gupta PK, Sharma M, Kochhar R. Pancreatic disease patients are at higher risk for Clostridium difficile infection compared to those with other co-morbidities. Gut Pathog 2019;11:17. [PMID: 31044014 DOI: 10.1186/s13099-019-0300-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
37 Ilett EE, Helleberg M, Reekie J, Murray DD, Wulff SM, Khurana MP, Mocroft A, Daugaard G, Perch M, Rasmussen A, Sørensen SS, Gustafsson F, Frimodt-Møller N, Sengeløv H, Lundgren J. Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Open Forum Infect Dis 2019;6:ofz086. [PMID: 30949533 DOI: 10.1093/ofid/ofz086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
38 Rolak S, Di Bartolomeo S, Jorgenson MR, Saddler CM, Singh T, Astor BC, Parajuli S. Outcomes of Norovirus diarrheal infections and Clostridioides difficile infections in kidney transplant recipients: A single‐center retrospective study. Transpl Infect Dis 2019;21:e13053. [DOI: 10.1111/tid.13053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Hand J. Strategies for Antimicrobial Stewardship in Solid Organ Transplant Recipients. Infect Dis Clin North Am 2018;32:535-50. [PMID: 30146022 DOI: 10.1016/j.idc.2018.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
40 Hassoun A. Clostridium difficile associated disease. BMJ 2018;363:k4369. [PMID: 30373736 DOI: 10.1136/bmj.k4369] [Reference Citation Analysis]
41 Lin SC, Alonso CD, Moss AC. Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature. Transpl Infect Dis 2018;20:e12967. [PMID: 30011107 DOI: 10.1111/tid.12967] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
42 Korayem GB, Eljaaly K, Matthias KR, Zangeneh TT. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study. Transplant Proc 2018;50:137-41. [PMID: 29407296 DOI: 10.1016/j.transproceed.2017.11.016] [Reference Citation Analysis]
43 Florescu DF. The evaluation of critically ill transplant patients with infectious diarrhea. Curr Opin Crit Care 2017;23:364-71. [PMID: 28759468 DOI: 10.1097/MCC.0000000000000444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Nosotti M, Tarsia P, Morlacchi LC. Infections after lung transplantation. J Thorac Dis 2018;10:3849-68. [PMID: 30069386 DOI: 10.21037/jtd.2018.05.204] [Cited by in Crossref: 26] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
45 Aguilar C, Husain S, Lortholary O. Recent advances in understanding and managing infectious diseases in solid organ transplant recipients. F1000Res 2018;7:F1000 Faculty Rev-661. [PMID: 29899970 DOI: 10.12688/f1000research.14262.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
46 Kalil AC, Sandkovsky U, Florescu DF. Severe infections in critically ill solid organ transplant recipients. Clin Microbiol Infect 2018;24:1257-63. [PMID: 29715551 DOI: 10.1016/j.cmi.2018.04.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
47 Nguyen CT, Li J, Anders S, Garcia-Diaz J, Staffeld-Coit C, Hand J. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study. Transpl Infect Dis 2018;20:e12867. [PMID: 29512244 DOI: 10.1111/tid.12867] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
48 Luo R, Weinberg JM, Barlam TF. The Impact of Clostridium difficile Infection on Future Outcomes of Solid Organ Transplant Recipients. Infect Control Hosp Epidemiol 2018;39:563-70. [PMID: 29553007 DOI: 10.1017/ice.2018.48] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
49 Guzman L, Qiu F, Kalil AC, Mercer DF, Langnas A, Florescu DF. Risk factors for Clostridium difficile infection in intestinal transplant recipients during the first year post-transplant. Transpl Infect Dis 2018;20:e12858. [PMID: 29427406 DOI: 10.1111/tid.12858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
50 Dubberke ER, Reske KA, Olsen MA, Bommarito K, Cleveland AA, Silveira FP, Schuster MG, Kauffman CA, Avery RK, Pappas PG, Chiller TM. Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients. Transpl Infect Dis 2018;20:e12855. [PMID: 29427356 DOI: 10.1111/tid.12855] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
51 Schneider KM, Wirtz TH, Kroy D, Albers S, Neumann UP, Strowig T, Sellge G, Trautwein C. Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation. Case Rep Gastroenterol 2018;12:76-84. [PMID: 29606940 DOI: 10.1159/000481937] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
52 Cusini A, Béguelin C, Stampf S, Boggian K, Garzoni C, Koller M, Manuel O, Meylan P, Mueller NJ, Hirsch HH, Weisser M, Berger C, van Delden C; Swiss Transplant Cohort Study. Clostridium difficile infection is associated with graft loss in solid organ transplant recipients. Am J Transplant 2018;18:1745-54. [PMID: 29349869 DOI: 10.1111/ajt.14640] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
53 Splinter LE, Kerstenetzky L, Jorgenson MR, Descourouez JL, Leverson GE, Saddler CM, Smith JA, Safdar N, Redfield RR. Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients. Ann Pharmacother 2017;52:113-9. [DOI: 10.1177/1060028017727756] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
54 Florescu DF, Sandkovsky U, Kalil AC. Sepsis and Challenging Infections in the Immunosuppressed Patient in the Intensive Care Unit. Infect Dis Clin North Am 2017;31:415-34. [PMID: 28687212 DOI: 10.1016/j.idc.2017.05.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
55 Bonatti HJR, Sadik KW, Krebs ED, Sifri CD, Pruett TL, Sawyer RG. Clostridium difficile-Associated Colitis Post-Transplant Is Not Associated with Elevation of Tacrolimus Concentrations. Surg Infect (Larchmt) 2017;18:689-93. [PMID: 28650734 DOI: 10.1089/sur.2016.180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Khumra S, Chan J, Urbancic K, Worland T, Angus P, Jones R, Grayson ML, Trubiano JA. Antibiotic Allergy Labels in a Liver Transplant Recipient Study. Antimicrob Agents Chemother 2017;61:e00078-17. [PMID: 28264847 DOI: 10.1128/AAC.00078-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
57 Bruminhent J, Cawcutt KA, Thongprayoon C, Petterson TM, Kremers WK, Razonable RR. Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients. Clin Transplant 2017;31. [PMID: 28314071 DOI: 10.1111/ctr.12968] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
58 Flannigan KL, Rajbar T, Moffat A, McKenzie LS, Dicke F, Rioux K, Workentine ML, Louie TJ, Hirota SA, Greenway SC. Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in a Pediatric Heart Transplant Patient. Front Cardiovasc Med 2017;4:17. [PMID: 28421185 DOI: 10.3389/fcvm.2017.00017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
59 Curry SR. Clostridium difficile. Clin Lab Med 2017;37:341-69. [PMID: 28457354 DOI: 10.1016/j.cll.2017.01.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
60 Cózar-Llistó A, Ramos-Martinez A, Cobo J. Clostridium difficile Infection in Special High-Risk Populations. Infect Dis Ther 2016;5:253-69. [PMID: 27515721 DOI: 10.1007/s40121-016-0124-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
61 Donnelly JP, Wang HE, Locke JE, Mannon RB, Safford MM, Baddley JW. Hospital-onset Clostridium difficile infection among solid organ transplant recipients. Am J Transplant 2015;15:2970-7. [PMID: 26484839 DOI: 10.1111/ajt.13491] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
62 Cervantes J. Use your antibiotics wisely. Consequences to the intestinal microbiome. FEMS Microbiol Lett 2016;363:fnw081. [PMID: 27044298 DOI: 10.1093/femsle/fnw081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
63 Greendyke WG, Pereira MR. Infectious Complications and Vaccinations in the Posttransplant Population. Med Clin North Am 2016;100:587-98. [PMID: 27095647 DOI: 10.1016/j.mcna.2016.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
64 Pergam SA. Infection Prevention in Transplantation. Curr Infect Dis Rep 2016;18:7. [PMID: 26820654 DOI: 10.1007/s11908-015-0513-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
65 Curry S. Clostridium difficile. Clin Lab Med. 2010;30:329-342. [PMID: 20513554 DOI: 10.1016/j.cll.2010.04.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]